×
AllNewsMapsShopping Images Videos Books
Search tools
Showing results for Biohaven Pharma.hldg Co.ltd.
Search instead for Biohaven Pharmac.hldg Co.ltd.

Biohaven Becomes Oversold (BHVN)

Nasdaq
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.
3 weeks ago

How This Manufacturer Turned Big Pharma's Commercialization Model Upside Down

Forbes
When Pfizer PFE +0.7% (NYSE: PFE) acquired Biohaven Pharmaceutical Holding Company Ltd., the maker of a portfolio of calcitonin gene-related...
9 months ago

Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments

PR Newswire
Acquired exclusive license for oral, brain-penetrant, dual TYK2/JAK1 inhibitor for immune-mediated brain disorders in March 2023 covering...
14 months ago

Pfizer to Acquire Biohaven Pharmaceuticals

Business Wire
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the companies have entered into a...
24 months ago

Pfizer's Biohaven Deal May Open an Era of Smarter Pharma Acquisitions

Bloomberg
The drug giant's purchase comes as good news for investors desperate for biotech M&A. It's also a sensible addition to Pfizer's portfolio.
24 months ago

Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite

Fierce Biotech
A new, slimmed-down Biohaven issued its debut earnings release post-Pfizer split, touting a $301.9 million fundraising and new executive...
18 months ago

Pfizer's Biohaven $11.6B takeout could fuel its spinout through the bear market

BioCentury
Pfizer's $11.6 billion acquisition of Biohaven is the latest example of an alternative financing structure biotechs are using to survive the...
24 months ago

Document

SEC.gov
Zavegepant is a third generation, high affinity, selective and structurally unique, small molecule CGRP receptor antagonist from Biohaven's...
28 months ago

Biohaven's ALS drug fails to meet study goals

Reuters
Biohaven Pharmaceutical Holding Company Ltd said on Thursday its experimental drug to treat amyotrophic lateral sclerosis (ALS) failed a...
20 months ago

Biohaven Acquires Remaining Stake In Kleo Pharmaceuticals

Contract Pharma
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.
40 months ago